Related references
Note: Only part of the references are listed.Forced vital capacity predicts the survival of interstitial lung disease in anti-MDA5 positive dermatomyositis: a multi-centre cohort study
Wanlong Wu et al.
RHEUMATOLOGY (2022)
Interstitial Lung Disease in Anti-MDA5 Positive Dermatomyositis
Wanlong Wu et al.
CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY (2021)
Study of Tofacitinib in Refractory Dermatomyositis: An Open-Label Pilot Study of Ten Patients
Julie J. Paik et al.
ARTHRITIS & RHEUMATOLOGY (2021)
239th ENMC International Workshop: Classification of dermatomyositis, Amsterdam, the Netherlands, 14-16 December 2018
Andrew L. Mammen et al.
NEUROMUSCULAR DISORDERS (2020)
Aberrant activation of the type I interferon system may contribute to the pathogenesis of anti-melanoma differentiation-associated gene 5 dermatomyositis
S. H. Zhang et al.
BRITISH JOURNAL OF DERMATOLOGY (2019)
A Balancing Act: MDA5 in Antiviral Immunity and Autoinflammation
Antonio Gregorio Dias Junior et al.
TRENDS IN MICROBIOLOGY (2019)
Tofacitinib in Amyopathic Dermatomyositis-Associated Interstitial Lung Disease
Zhiwei Chen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Comparative Structure and Function Analysis of the RIG-I-Like Receptors: RIG-I and MDA5
Morgan Brisse et al.
FRONTIERS IN IMMUNOLOGY (2019)
Tofacitinib for refractory interstitial lung diseases in anti-melanoma differentiation-associated 5 gene antibody-positive dermatomyositis
Kazuhiro Kurasawa et al.
RHEUMATOLOGY (2018)
Clinical Utility of an Enzyme-Linked Immunosorbent Assay for Detecting Anti-Melanoma Differentiation-Associated Gene 5 Autoantibodies
Shinji Sato et al.
PLOS ONE (2016)
Neutrophil Extracellular Trap Mitochondrial DNA and Its Autoantibody in Systemic Lupus Erythematosus and a Proof-of-Concept Trial of Metformin
Haiting Wang et al.
ARTHRITIS & RHEUMATOLOGY (2015)
Serum interferon-α is a useful biomarker in patients with anti-melanoma differentiation-associated gene 5 (MDA5) antibody-positive dermatomyositis
Yoshiro Horai et al.
MODERN RHEUMATOLOGY (2015)
Genetic polymorphisms of dsRNA ligating pattern recognition receptors TLR3, MDA5, and RIG-I. Association with systemic lupus erythematosus and clinical phenotypes
C. Enevold et al.
RHEUMATOLOGY INTERNATIONAL (2014)
C-Reactive Protein Inhibits Plasmacytoid Dendritic Cell Interferon Responses to Autoantibody Immune Complexes
Carolyn Mold et al.
ARTHRITIS AND RHEUMATISM (2013)
The type I interferon system in the development of lupus
Lars Ronnblom et al.
SEMINARS IN IMMUNOLOGY (2011)
Epidemiologic study of clinically amyopathic dermatomyositis and anti-melanoma differentiation-associated gene 5 antibodies in central Japan
Yoshinao Muro et al.
ARTHRITIS RESEARCH & THERAPY (2011)
Association of NCF2, IKZF1, IRF8, IFIH1, and TYK2 with Systemic Lupus Erythematosus
Deborah S. Cunninghame Graham et al.
PLOS GENETICS (2011)
Regulation of the Interferon-α Production Induced by RNA-Containing Immune Complexes in Plasmacytoid Dendritic Cells
Maija-Leena Eloranta et al.
ARTHRITIS AND RHEUMATISM (2009)
RNA Helicase Encoded by Melanoma Differentiation-Associated Gene 5 Is a Major Autoantigen in Patients With Clinically Amyopathic Dermatomyositis Association With Rapidly Progressive Interstitial Lung Disease
Shinji Sato et al.
ARTHRITIS AND RHEUMATISM (2009)
Association of increased interferon-inducible gene expression with disease activity and lupus nephritis in patients with systemic lupus erythematosus
Xuebing Feng et al.
ARTHRITIS AND RHEUMATISM (2006)
Share Paper
